Good MorningThe sell-off on Wall Street picked up momentum last week following the hotter-than-expected CPI data. The data showed an unexpected acceleration in consumer level inflation that has the FOMC on track to hike rates by another 75 basis points this week at least. The risk now is the FOMC will try to front-run the inflation because it is so far behind the curve and that would mean even more aggressive actions and possibly a 100 basis points interest rate hike. The takeaway for investors is that economic conditions are changing rapidly and soft-landing may be impossible to orchestrate.
Also on tap this week is a raft of housing data including the NAHB index, permits, starts, and existing home sales. More importantly, we'll get a read on the index of leading indicators and it is expected to be negative. If so, this would be the 5th consecutive month of negative readings and may indicate the contraction in economic activity caused by inflation and the Fed is getting worse. Featured: Wall Street’s quietly buying these 3 AI infrastructure plays (Ad) 
|
Retail/Wholesale | | Grocery chain operator The Kroger Company (NYSE: KR) stock is trading up 4.5% in 2022 far outperforming tech stocks and the benchmark indices. The Company operates approximately 2,800 grocery store and pharmacies under two dozen banners in the 35 states and also sells fuel through over 1,600 centers... Read the Full Story |
|
From Our Partners | | BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid.
The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned. | | Get the name, the ticker, and exactly how to buy it |
|
Technology | | Riddle me this, how do you shock investors into a two-day selling frenzy vaporizing (-20%) off your share price and (-30%) off your market cap just after releasing great earnings? Answer, by announcing a cash and stock acquisition paying 50X sales ($20 billion) for a company with $400 million ARR in... Read the Full Story |
|
Markets | | The Inflation Reduction Act (IRA) was signed into law by President Joe Biden on August 16, 2022. The intent of which is to lower inflation by lowering the costs for health, raise funding for the IRS, and funding decarbonization efforts through energy and climate projects reducing carbon emissions by... Read the Full Story |
|
From Our Partners | | See the Signals Most Traders Miss
We monitor subtle shifts in order flow, volume patterns, and early trend behavior.
Stock News Trends highlights moves long before they hit mainstream screens. | | Join Free — Start Tracking Early Market Data |
|
Retail/Wholesale | | There is a very great chance the S&P 500 (NYSEARCA: SPY) could fall another 25% or more but the news is not bad for all stocks. The hurricane predicted by Jamie Dimon is upon us, some others say the economy is broken, and yet there are sectors, industries, and individual stocks that are still se... Read the Full Story |
|
Finance | |
Rates will continue to climb with inflation concerns
Finding opportunities is becoming more difficult
Could bank stocks be about to turn around and head north?
With the Fed continuing to take us into a rising interest rate cycle, you’d be forgiven for thinking that banks would be one... Read the Full Story |
|
From Our Partners | | With OpenAI and Anthropic moving closer to the IPO spotlight, AI excitement could spill into several public-market sectors this summer - and most investors may chase the obvious names too late.
A free report identifies 7 stocks positioned around themes that could matter most this summer: AI infrastructure, energy demand, travel, entertainment, home improvement, and more. Built for a market where leadership may rotate quickly. | | Download 7 Best Stocks to Own in Summer 2026 for free |
|
Medical | |
U.S. stocks suffered their biggest one-day drop in more than two years on Tuesday.
Oil & gas companies as well as auto manufacturers have managed to move higher.
At the individual stock level, there have also been some interesting contrarian movers
Yes, the market’s strong Septemb... Read the Full Story |
|
Medical | |
What’s gone right and what is still off about TDOC stock
TDOC stock went “to the moon” for most of 2020 and the early part of 2021.
Today, TDOC stock is trading at a five-year low.
One of the more intriguing pandemic stocks in my opinion was Teladoc Health (NYSE: TDOC). T... Read the Full Story |
|
Markets | |
You've likely heard of the company Colgate-Palmolive, particularly if you're a big fan of that brand of toothpaste. However, the Colgate-Palmolive Company (NYSE: CL) produces so many more products than just toothpaste. Let's take a look at some facts about Colgate-Palmolive Company as well as some... Read the Full Story |
|
Medical | |
The stock returned 58.36% in the past three months
On a fundamental basis, strong sales and earnings growth has bolstered its strength
Now guiding to overall revenue growth of 18-21%
There are plenty of steps and partner companies involved with producing any product within the pharmaceutica... Read the Full Story |
|
Finance | |
To be fair, Arbor Realty Trust (NYSE: ABR) is not a stock but a REIT but yes, its 10% yielding units are worth it. Yes, I know that REITs come with tax implications that make them less attractive for average investors and in regular accounts but they are an investment vehicle with many attractive ... Read the Full Story |
|
Monday's Early Bird Stock Of The Day Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France. | | View Today's Stock Pick |
|
